GH1 and Prader-Willi syndrome: The prescription of r-hGH has now been approved and licensed to treat several growth-related indications, which include Growth Hormone Deficiency (GHD), Turner Syndrome (TS) Small for Gestational Age (SGA) with failure to catch up, Idiopathic Short Stature (ISS), Russell Silver Syndrome (RSS), Prader-Willi Syndrome (PWS) Short stature HomeobOX-containing gene (SHOX) deficiency, Chronic Renal Insufficiency (CRI) and Noonan Syndrome (NS) (2).